SELLAS Life Sciences Group, Inc.
US ˙ NasdaqCM ˙ US81642T2096

SecuritySLS / SELLAS Life Sciences Group, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in SLS / SELLAS Life Sciences Group, Inc.

On May 10, 2024 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of SELLAS Life Sciences Group, Inc. (US:SLS) valued at $0 USD as of March 31, 2024. The entity filed a previous 13F-HR on February 14, 2024 disclosing 186,355 shares of SELLAS Life Sciences Group, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (SLS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SLS / SELLAS Life Sciences Group, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-05-10 2024-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 0 -186,355 -100.00 0 -100.00
2024-02-14 2023-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 186,355 186,355 198 0.0005
2022-05-11 2022-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 0 -5,578 -100.00 0 -100.00
2022-02-11 2021-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 5,578 5,528 11,056.00 31 0.0000
2021-11-12 2021-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 50 50 0 0.0000
2021-08-10 2021-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 0 -27,237 -100.00 0 -100.00
2021-05-12 2021-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 27,237 27,235 1,361,750.00 233 0.0003
2021-02-10 2020-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 2 0 0.00 0 -100.00 0.0000
2020-11-12 2020-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 2 0 0.00 0 0.0000
2020-08-13 2020-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 2 0 0.00 0 0.0000
2020-05-13 2020-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 2 0 0.00 0 0.0000
2020-02-10 2019-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW 81642T209 2 2 -98.59 0 0.0000
2017-05-10 2017-03-31 13F GALENA BIOPHARMA COM NEW 363256504 0 -2,968 -100.00 0 -100.00
2017-02-15 2016-12-31 13F GALENA BIOPHARMA COM NEW 363256504 2,968 -132,050 -97.80 6 -87.23 0.0001
2016-11-14 2016-09-30 13F GALENA BIOPHARMA COM 363256108 135,018 -831,050 -86.02 47 -89.56 0.0005
2016-08-12 2016-06-30 13F GALENA BIOPHARMA COM 363256108 966,068 966,068 615.51 450 857.45 0.0053
2016-05-12 2016-03-31 13F GALENA BIOPHARMA COM 363256108 0 -1,346,904 -100.00 0 -100.00
2016-02-11 2015-12-31 13F GALENA BIOPHARMA COM 363256108 1,346,904 84,190 6.67 1,980 -0.75 0.0234
2015-11-20 2015-09-30 13F/A-1 GALENA BIOPHARMA COM 363256108 1,262,714 568,381 81.86 1,995 69.07 0.0276
2015-11-06 2015-09-30 13F GALENA BIOPHARMA COM 363256108 1,262,714 1,995
2015-08-11 2015-06-30 13F GALENA BIOPHARMA COM 363256108 694,333 414,633 148.24 1,180 203.34 0.0165
2015-05-14 2015-03-31 13F GALENA BIOPHARMA COM 363256108 279,700 -179,252 -39.06 389 -43.87 0.0061
2015-02-11 2014-12-31 13F GALENA BIOPHARMA COM 363256108 458,952 -80,079 -14.86 693 -37.57 0.0105
2014-10-31 2014-09-30 13F GALENA BIOPHARMA COM 363256108 539,031 120,403 28.76 1,110 -13.35 0.0171
2014-08-12 2014-06-30 13F GALENA BIOPHARMA COM 363256108 418,628 -127,198 -23.30 1,281 -6.15 0.0197
2014-05-07 2014-03-31 13F GALENA BIOPHARMA COM 363256108 545,826 545,826 1,365 0.0230
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 11,206,600 17.78 42,249 175.81 n/a n/a n/a
2025-11-12 2025-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 9,514,600 137.39 15,319 74.52 n/a n/a n/a
2025-08-14 2025-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 4,008,000 93.63 8,778 292.71 n/a n/a n/a
2025-05-14 2025-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 2,069,900 -7.77 2,235 -4.20 n/a n/a n/a
2025-05-14 2024-12-31 13F/A SELLAS LIFE SCIENCES GROUP I COM NEW Call 2,244,200 19.58 2,334 -0.55 n/a n/a n/a
2025-02-14 2024-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 2,244,200 2,334 n/a n/a n/a
2024-11-14 2024-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 1,876,800 -26.06 2,346 -22.32 n/a n/a n/a
2024-08-14 2024-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 2,538,300 251.52 3,021 314.27 n/a n/a n/a
2024-05-10 2024-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 722,100 685.75 729 651.55 n/a n/a n/a
2024-02-14 2023-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 91,900 -68.77 97 -79.88 n/a n/a n/a
2023-11-09 2023-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 294,300 89.87 483 98.35 n/a n/a n/a
2023-08-09 2023-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 155,000 -24.72 243 -17.35 n/a n/a n/a
2023-05-12 2023-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 205,900 70.59 294 3.52 n/a n/a n/a
2023-02-09 2022-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 120,700 7.86 285 25.66 n/a n/a n/a
2022-11-09 2022-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 111,900 -3.53 226 -12.74 n/a n/a n/a
2022-08-11 2022-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 116,000 47.96 259 -50.57 n/a n/a n/a
2022-05-12 2022-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 78,400 412.42 524 516.47 n/a n/a n/a
2022-02-11 2021-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 15,300 -28.84 85 -56.85 n/a n/a n/a
2021-11-12 2021-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 21,500 -65.54 197 -71.57 n/a n/a n/a
2021-08-10 2021-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 62,400 387.50 693 535.78 n/a n/a n/a
2021-05-12 2021-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 12,800 1,322.22 109 2,080.00 n/a n/a n/a
2021-02-10 2020-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Call 900 -92.97 5 -95.41 n/a n/a n/a
2019-05-14 2019-03-31 13F/A SELLAS LIFE SCIENCES GROUP I COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-05 2018-12-31 13F SELLAS LIFE SCIENCES GROUP I COM Call 57,700 0.00 71 1.43 n/a n/a n/a
2018-11-08 2018-09-30 13F SELLAS LIFE SCIENCES GROUP I COM Call 57,700 0.00 70 -64.47 n/a n/a n/a
2018-08-13 2018-06-30 13F SELLAS LIFE SCIENCES GROUP I COM Call 57,700 11.18 197 10.06 n/a n/a n/a
2018-05-16 2018-03-31 13F/A SELLAS LIFE SCIENCES GROUP I COM Call 51,900 -94.18 179 -23.50 n/a n/a n/a
2018-05-10 2018-03-31 13F SELLAS LIFE SCIENCES GROUP I COM Call 51,900 179 n/a n/a n/a
2018-02-09 2017-12-31 13F GALENA BIOPHARMA COM NEW Call 892,100 -0.07 234 -25.71 n/a n/a n/a
2017-11-15 2017-09-30 13F GALENA BIOPHARMA COM NEW Call 892,700 0.34 315 -39.07 n/a n/a n/a
2017-08-14 2017-06-30 13F GALENA BIOPHARMA COM NEW Call 889,700 -1.24 517 -6.00 n/a n/a n/a
2017-05-10 2017-03-31 13F GALENA BIOPHARMA COM NEW Call 900,900 -75.70 550 -92.35 n/a n/a n/a
2017-02-15 2016-12-31 13F GALENA BIOPHARMA COM NEW Call 3,706,700 -5.57 7,191 422.98 n/a n/a n/a
2016-11-14 2016-09-30 13F GALENA BIOPHARMA COM Call 3,925,400 -4.34 1,375 -28.12 n/a n/a n/a
2016-08-12 2016-06-30 13F GALENA BIOPHARMA COM Call 4,103,700 12.31 1,913 -61.50 n/a n/a n/a
2016-05-12 2016-03-31 13F GALENA BIOPHARMA COM Call 3,653,900 378.70 4,969 342.87 n/a n/a n/a
2016-02-11 2015-12-31 13F GALENA BIOPHARMA COM Call 763,300 4.39 1,122 -2.86 n/a n/a n/a
2015-11-20 2015-09-30 13F/A GALENA BIOPHARMA COM Call 731,200 -31.06 1,155 -35.94 n/a n/a n/a
2015-11-06 2015-09-30 13F GALENA BIOPHARMA COM Call 731,200 1,155 n/a n/a n/a
2015-08-11 2015-06-30 13F GALENA BIOPHARMA COM Call 1,060,600 48.40 1,803 81.57 n/a n/a n/a
2015-05-14 2015-03-31 13F GALENA BIOPHARMA COM Call 714,700 6.29 993 -2.17 n/a n/a n/a
2015-02-11 2014-12-31 13F GALENA BIOPHARMA COM Call 672,400 -19.52 1,015 -41.02 n/a n/a n/a
2014-10-31 2014-09-30 13F GALENA BIOPHARMA COM Call 835,500 -29.19 1,721 -52.34 n/a n/a n/a
2014-08-12 2014-06-30 13F GALENA BIOPHARMA COM Call 1,180,000 -19.53 3,611 -1.50 n/a n/a n/a
2014-05-07 2014-03-31 13F GALENA BIOPHARMA COM Call 1,466,400 32.02 3,666 -33.45 n/a n/a n/a
2014-01-31 2013-12-31 13F GALENA BIOPHARMA COM Call 1,110,700 144.59 5,509 434.34 n/a n/a n/a
2013-11-15 2013-09-30 13F GALENA BIOPHARMA COM Call 454,100 289.12 1,031 298.07 n/a n/a n/a
2013-08-02 2013-06-30 13F GALENA BIOPHARMA COM Call 116,700 259 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 676,500 2,014.06 2,550 4,900.00 n/a n/a n/a
2025-11-12 2025-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 32,000 91.62 52 41.67 n/a n/a n/a
2025-08-14 2025-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 16,700 53.21 37 227.27 n/a n/a n/a
2025-05-14 2025-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 10,900 445.00 12 450.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A SELLAS LIFE SCIENCES GROUP I COM NEW Put 2,000 0.00 2 0.00 n/a n/a n/a
2025-02-14 2024-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 2,000 2 n/a n/a n/a
2024-11-14 2024-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 2,000 2 n/a n/a n/a
2024-05-10 2024-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 1,700 0.00 2 -50.00 n/a n/a n/a
2023-11-09 2023-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 1,700 0.00 3 0.00 n/a n/a n/a
2023-08-09 2023-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 1,700 -54.05 3 -60.00 n/a n/a n/a
2023-05-12 2023-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 3,700 -13.95 5 -50.00 n/a n/a n/a
2023-02-09 2022-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 4,300 -17.31 10 -9.09 n/a n/a n/a
2022-11-09 2022-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 5,200 -25.71 11 -31.25 n/a n/a n/a
2022-08-11 2022-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 7,000 37.25 16 -52.94 n/a n/a n/a
2022-05-12 2022-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 5,100 112.50 34 161.54 n/a n/a n/a
2022-02-11 2021-12-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 2,400 20.00 13 -27.78 n/a n/a n/a
2021-11-12 2021-09-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 2,000 -69.23 18 -75.00 n/a n/a n/a
2021-08-10 2021-06-30 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 6,500 -56.67 72 -43.75 n/a n/a n/a
2021-05-12 2021-03-31 13F SELLAS LIFE SCIENCES GROUP I COM NEW Put 15,000 130.77 128 77.78 n/a n/a n/a
2019-05-14 2019-03-31 13F/A SELLAS LIFE SCIENCES GROUP I COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-05 2018-12-31 13F SELLAS LIFE SCIENCES GROUP I COM Put 3,200 0.00 4 0.00 n/a n/a n/a
2018-11-08 2018-09-30 13F SELLAS LIFE SCIENCES GROUP I COM Put 3,200 0.00 4 -63.64 n/a n/a n/a
2018-08-13 2018-06-30 13F SELLAS LIFE SCIENCES GROUP I COM Put 3,200 0.00 11 0.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A SELLAS LIFE SCIENCES GROUP I COM Put 3,200 -91.84 11 10.00 n/a n/a n/a
2018-05-10 2018-03-31 13F SELLAS LIFE SCIENCES GROUP I COM Put 3,200 11 n/a n/a n/a
2018-02-09 2017-12-31 13F GALENA BIOPHARMA COM NEW Put 39,200 176.06 10 100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F GALENA BIOPHARMA COM NEW Put 14,200 -51.54 5 -70.59 n/a n/a n/a
2017-08-14 2017-06-30 13F GALENA BIOPHARMA COM NEW Put 29,300 253.01 17 240.00 n/a n/a n/a
2017-05-10 2017-03-31 13F GALENA BIOPHARMA COM NEW Put 8,300 -94.39 5 -98.26 n/a n/a n/a
2017-02-15 2016-12-31 13F GALENA BIOPHARMA COM NEW Put 148,000 -29.82 287 287.84 n/a n/a n/a
2016-11-14 2016-09-30 13F GALENA BIOPHARMA COM Put 210,900 -58.49 74 -68.78 n/a n/a n/a
2016-08-12 2016-06-30 13F GALENA BIOPHARMA COM Put 508,100 2,220.09 237 690.00 n/a n/a n/a
2016-05-12 2016-03-31 13F GALENA BIOPHARMA COM Put 21,900 -97.48 30 -97.65 n/a n/a n/a
2016-02-11 2015-12-31 13F GALENA BIOPHARMA COM Put 869,200 11.28 1,278 3.57 n/a n/a n/a
2015-11-20 2015-09-30 13F/A GALENA BIOPHARMA COM Put 781,100 -16.53 1,234 -22.44 n/a n/a n/a
2015-11-06 2015-09-30 13F GALENA BIOPHARMA COM Put 781,100 1,234 n/a n/a n/a
2015-08-11 2015-06-30 13F GALENA BIOPHARMA COM Put 935,800 64.15 1,591 100.88 n/a n/a n/a
2015-05-14 2015-03-31 13F GALENA BIOPHARMA COM Put 570,100 -27.51 792 -33.33 n/a n/a n/a
2015-02-11 2014-12-31 13F GALENA BIOPHARMA COM Put 786,500 -27.09 1,188 -46.53 n/a n/a n/a
2014-10-31 2014-09-30 13F GALENA BIOPHARMA COM Put 1,078,700 -46.89 2,222 -64.25 n/a n/a n/a
2014-08-12 2014-06-30 13F GALENA BIOPHARMA COM Put 2,031,200 15.01 6,215 40.77 n/a n/a n/a
2014-05-07 2014-03-31 13F GALENA BIOPHARMA COM Put 1,766,100 192.26 4,415 47.31 n/a n/a n/a
2014-01-31 2013-12-31 13F GALENA BIOPHARMA COM Put 604,300 376.20 2,997 940.63 n/a n/a n/a
2013-11-15 2013-09-30 13F GALENA BIOPHARMA COM Put 126,900 474.21 288 487.76 n/a n/a n/a
2013-08-02 2013-06-30 13F GALENA BIOPHARMA COM Put 22,100 49 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.